Allergic eye disease is common, yet often overlooked in North America. In the U.S., up to 40% of the population is deemed to be affected and this number is growing. Symptoms and signs of ocular allergy can lead to decreased productivity and negatively impact quality of life (QoL). Various treatment options exist to achieve symptom control. For allergic conjunctivitis, ophthalmic agents include antihistamines, mast cell stabilizers, dual-activity agents, nonsteroidal anti-inflammatory drugs (NSAIDs), steroids and some off-label treatments. Immunotherapy is recommended as a therapeutic option. This review provides a summary of the forms of ocular allergies, with a focus on symptoms and signs, impact on QoL, physical examination, diagnosis and therapeutic options of allergic conjunctivitis. Through multidisciplinary collaborations, a simplified algorithm for the treatment of allergic conjunctivitis is proposed for Canadian clinical practice.

中文翻译：

---

过敏性结膜炎的当代观察。

过敏性眼病很常见，但在北美却经常被忽视。在美国，多达40％的人口被视为受影响，而且这一数字还在不断增加。眼部过敏的症状和体征可能导致生产力下降，并对生活质量（QoL）产生负面影响。存在多种治疗选择以实现症状控制。对于过敏性结膜炎，眼科药物包括抗组胺药，肥大细胞稳定剂，双重活性药物，非甾体类抗炎药（NSAIDs），类固醇和一些标签外治疗。建议将免疫疗法作为治疗选择。这篇综述总结了眼部过敏的形式，重点是过敏性结膜炎的症状和体征，对生活质量的影响，体格检查，诊断和治疗选择。通过多学科合作，